Therefore, to evaluate the interaction between GV, food intake, and diabetes mellitus treatment regimen, we enrolled 16 patients with type 2 diabetes who were under a pre-mixed insulin regimen and applied the first CGM. This evidence concerns the gene INS and type 2 diabetes mellitus.